Price movement over the last 24 hours
Agilent Technologies Inc vs Samsara Inc — how do they compare? Agilent Technologies Inc trades at $128.24 (market cap $37.04B), while Samsara Inc trades at $35.68 (market cap $21.18B). The key difference: Agilent Technologies Inc is the larger of the two by market cap, and Agilent Technologies Inc pays a 0.78% dividend while Samsara Inc pays none. Which is the better fit depends on your goals.
| A | IOT | |
|---|---|---|
Market Cap | $37.04B | $21.18B |
Sector | Health | Technology |
52-Week High | $157.20 | $45.22 |
52-Week Low | $110.24 | $24.25 |
Enterprise Value | $38.59B | $20.44B |
Dividend Yield | 0.78% | — |
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $131.14, up 0.34% on the day, with a bearish technical signal but strong analyst support. The stock shows solid profitability with a net margin of 19.55% and ROE of 21.33%, supported by recent earnings beats. Recent acquisitions like Biocare Medical highlight growth initiatives, while cash flow trends remain positive. Valuation ratios such as P/E of 26.22 are elevated but align with quality growth expectations.
The outlook is positive given analyst consensus with a $154.90 price target and 77.5% buy ratings. Risks include execution of acquisitions and macroeconomic pressures on life sciences spending. The stock offers growth potential from AI-driven product launches, though technical resistance near $132 may cap near-term gains.
Samsara (IOT) trades at $37.51, up 4.4% with strong bullish technical signals and consistent earnings beats. The company shows robust revenue growth projection from $1.25B (2025) to $1.7B (2026) and improving profitability, though current valuation metrics remain elevated with P/E of 375. Recent product launches including tracking labels and AI capabilities demonstrate innovation momentum in the connected operations space.
While analyst consensus remains strongly bullish with 78% buy ratings and $44.40 price target, investors face valuation concerns and execution risks as the company transitions toward profitability. The stock's technical overbought condition near resistance levels suggests potential near-term consolidation before further upside.
Trailing returns across standard periods
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →Samsara provides a connected operations cloud that uses IoT data to help businesses improve efficiency and safety. Its platform offers real-time visibility for fleet management, equipment monitoring, and industrial sites.
Read more on IOT →